title: Aging-related gene signature regulated by Nlrp3 predicts glioma progression.
abstract: Aging is the strongest risk factor for glioma development, suggesting that molecular crosstalks between aging and tumorigenesis exist in many cellular pathways. Recently, Nlrp3 inflammasome have been shown to modulate several major cellular pathways such as inflammation and cell death and have been demonstrated to be an upstream target that controlled the process of brain aging. We proposed Nlrp3 inflammasome may serve as a possible molecular link between aging and glioma progression. In this study, we generated a aging-related gene signature that regulated by Nlrp3 in mouse hippocampus and demonstrated that this gene signature can distinguish subsets of glioma samples and predicts clinical outcome in radiotherapy-treated patients. In addition, using U87 and GL261 xenograft mouse glioblastoma model, we found that Nlrp3 inflammasome contributed to radiotherapy resistance in glioma. Ionizing radiation can induce Nlrp3 inflammasome expression; Nlrp3 inhibition reduced tumor growth and prolonged the survival of mouse following IR treatment; Nlrp3 inhibition reduced number of senescent cells induced by IR. These results above suggest that Nlrp3 inflammasome is an important molecular link between brain aging and glioma progression; the Nlrp3 gene signature may serve as a predictive biomarker for glioma patients.
authors: Department of Neurosurgery, Qilu Hospital of Shandong University Jinan 250012, China ; Brain Science Research Institute of Shandong University Jinan 250012, China ; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University Jinan 250012, China.
authors: Lianling
authors: L
authors: Li
authors: Department of Neurosurgery, Qilu Hospital of Shandong University Jinan 250012, China ; Brain Science Research Institute of Shandong University Jinan 250012, China.
authors: Yuguang
authors: Y
authors: Liu
keywords: Nlrp3; aging; gene signature; glioma; radiotherapy
references: Lancet Oncol. 2009 May;10 (5):459-66
references: 19269895
references: Nat Rev Cancer. 2014 Aug;14(8):547-58
references: 25030953
references: Cell Metab. 2013 Oct 1;18(4):519-32
references: 24093676
references: Cell Death Dis. 2012 Dec 20;3:e446
references: 23254289
references: Cell Death Differ. 2011 Apr;18(4):666-77
references: 21072054
references: J Neurosci. 2009 Feb 11;29(6):1805-16
references: 19211887
references: Cancer Res. 2013 Jul 15;73(14):4267-77
references: 23722550
references: Immunity. 2013 Sep 19;39(3):432-41
references: 24054327
references: J Natl Cancer Inst. 1993 May 5;85(9):704-10
references: 8478956
references: Cancer Res. 2012 Nov 15;72 (22):5721-32
references: 22986739
references: Autophagy. 2014 Jul;10(7):1212-28
references: 24813621
references: EMBO Mol Med. 2012 Dec;4(12):1276-93
references: 23065753
references: Nat Protoc. 2009;4(12):1798-806
references: 20010931
references: Cancer Res. 2004 Oct 1;64(19):6892-9
references: 15466178
references: Nat Rev Neurosci. 2014 Feb;15(2):84-97
references: 24399084
references: J Natl Compr Canc Netw. 2013 Sep 1;11(9):1165-72; quiz 1173
references: 24029128
references: Cancer Cell. 2013 Sep 9;24(3):331-46
references: 23993863
references: Expert Rev Neurother. 2013 Oct;13(10 ):1099-105
references: 24117272
references: Nature. 2008 Oct 23;455(7216):1061-8
references: 18772890
references: Genes Dev. 2014 Jan 15;28(2):99-114
references: 24449267
references: Clin Cancer Res. 2012 May 1;18(9):2579-90
references: 22379115
references: J Neurosci. 2007 Mar 21;27(12):3098-110
references: 17376971
references: J Neurosci. 2003 May 1;23(9):3807-19
references: 12736351
references: Drug Resist Updat. 2012 Feb-Apr;15(1-2):123-31
references: 22365330
references: J Neurosci. 2010 Apr 28;30(17):6058-71
references: 20427664
references: Pharmacol Ther. 2014 Jul;143(1):24-33
references: 24518102
references: Nucleic Acids Res. 2014 Apr;42(8):e64
references: 24503249
references: Cancer Res. 2009 Dec 1;69(23):9065-72
references: 19920198
references: Neuro Oncol. 2010 Jun;12(6):520-7
references: 20511189
references: Oncotarget. 2014 Jul 15;5(13):4683-93
references: 24970813
references: Nat Rev Immunol. 2013 Jun;13(6):397-411
references: 23702978